Abstract

Macrophage fusion leading to the formation of multinucleated giant cells is a hallmark of chronic inflammation. Several membrane proteins have been implicated in mediating cell-cell attachment during fusion, but their binding partners remain unknown. Recently, we demonstrated that interleukin-4 (IL-4)-induced fusion of mouse macrophages depends on the integrin macrophage antigen 1 (Mac-1). Surprisingly, the genetic deficiency of intercellular adhesion molecule 1 (ICAM-1), an established ligand of Mac-1, did not impair macrophage fusion, suggesting the involvement of other counter-receptors. Here, using various approaches, including signal regulatory protein α (SIRPα) knockdown, recombinant proteins, adhesion and fusion assays, biolayer interferometry, and peptide libraries, we show that SIRPα, which, similar to ICAM-1, belongs to the Ig superfamily and has previously been implicated in cell fusion, interacts with Mac-1. The following results support the conclusion that SIRPα is a ligand of Mac-1: (a) recombinant ectodomain of SIRPα supports adhesion of Mac-1-expressing cells; (b) Mac-1-SIRPα interaction is mediated through the ligand-binding αMI-domain of Mac-1; (c) recognition of SIRPα by the αMI-domain conforms to general principles governing binding of Mac-1 to many of its ligands; (d) SIRPα reportedly binds CD47; however, anti-CD47 function-blocking mAb produced only a limited inhibition of macrophage adhesion to SIRPα; and (e) co-culturing of SIRPα- and Mac-1-expressing HEK293 cells resulted in the formation of multinucleated cells. Taken together, these results identify SIRPα as a counter-receptor for Mac-1 and suggest that the Mac-1-SIRPα interaction may be involved in macrophage fusion.

Highlights

  • Macrophage fusion leading to the formation of multinucleated giant cells is a hallmark of chronic inflammation

  • The following results support the conclusion that SIRP␣ is a ligand of macrophage antigen 1 (Mac-1): (a) recombinant ectodomain of SIRP␣ supports adhesion of Mac-1– expressing cells; (b) Mac-1–SIRP␣ interaction is mediated through the ligand-binding ␣MI-domain of Mac-1; (c) recognition of SIRP␣ by the ␣MIdomain conforms to general principles governing binding of Mac-1 to many of its ligands; (d) SIRP␣ reportedly binds CD47; anti-CD47 function-blocking mAb produced only a limited inhibition of macrophage adhesion to SIRP␣; and (e) co-culturing of SIRP␣- and Mac-1– expressing HEK293 cells resulted in the formation of multinucleated cells

  • We showed that SIRP␣ is expressed in mouse thioglycollate-elicited peritoneal macrophages, and its expression is increased by ϳ1.4-fold after 6 h in culture in the presence of fusion-promoting cytokine IL-4 and is gradually elevated (ϳ1.7-fold) until 48 h (Fig. S1, A and B)

Read more

Summary

Edited by Peter Cresswell

Macrophage fusion leading to the formation of multinucleated giant cells is a hallmark of chronic inflammation. The abbreviations used are: MGC, multinucleated giant cell; DMEM, Dulbecco’s modified Eagle’s medium; SIRP␣, signal regulatory protein ␣; m, mouse; h, human; MFR, macrophage fusion receptor; Ni-NTA, nickel-nitrilotriacetic acid; HBSS, Hanks’ balanced salt solution; PMA, phorbol 12-myristate 13-acetate; BLI, biolayer interferometry; PVP, polyvinylpyrrolidone; DAPI, 4Ј,6-diamidino-2-phenylindole. We established a cell-fusion system with HEK293 cells transfected separately with Mac-1 and SIRP␣ to show that co-culturing these cells in the presence of IL-4 results in cell fusion

Results
Residues mSIRPD
Discussion
Fluorescence intensity
Experimental procedures
Biolayer interferometry
Adhesion assays
Cell fusion
Flow cytometry
Statistical analyses
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call